Sanacurrents, Llc

SanaCurrents tracks market-moving catalysts of biopharmaceutical and medical technology stocks for the investment community. The company offers its independent research services on a subscription basis, publishing reports on approximately 50 catalyst events every year. SanaCurrents was founded to identify the most vital medical treatments in development. Typically, these important drugs and devices are backed by management and scientists committed to advancing new therapies. To develop novel treatments, drug and device developers must find an approach that improves the current standard of care for a disease and also provides a value proposition for clinicians. Companies then must commit to advancing thorough, patient-centric clinical trials. SanaCurrents evaluates these factors through objective data points to determine the strengths and weaknesses of vital treatments in development. The data points serve as the foundation for SanaCurrents’ proprietary analytics score, which forecasts the likelihood of a positive result weeks or months prior to an upcoming catalyst. By delivering the SanaCurrents analytics scores before anticipated catalysts, subscribers and SanaCurrents principals make appropriate investment decisions to maximize returns on the day of the catalyst. Sana is the imperative form of the verb sano in Latin, meaning “to heal or to cure now." For more information on the company, please email info@sanacurrents.com.